No, this isn't an article about how energy or agriculture stocks are on fire. This industry's growth isn't bound by the price of commodities, although it is associated with another business buzz word: outsourcing. Contract research organizations (CROs) do pre-clinical research and run clinical trials for drug developers on the cheap. With pharmaceutical companies like Wyeth (NYSE: , CROs are in the perfect position to benefit. Just look at the growth some of them have sustained over the past year: Source: Capital IQ, a division of Standard & Poor's; TTM = Trailing 12-month. Return was calculated through July 30, 2008. *Return from IPO price on Aug. 8, 2007; WuXi's year-ago TTM EPS were negative. There's something in that list for everyone. We've got a couple of international based stocks in Irish ICON and Chinese WuXi....
[read full story]
Your Web Site
